Weight Changes in Parkinsonian Patients, Treated With Deep Brain Stimulation
- Conditions
- Parkinson Disease
- Interventions
- Procedure: Deep brain stimulation
- Registration Number
- NCT00221793
- Lead Sponsor
- University Hospital, Bordeaux
- Brief Summary
The aim of this trial is to verify that neurostimulated parkinsonian patients gain weight and to study its link with an energetic balance change.
- Detailed Description
The aim of this trial is to verify that neurostimulated parkinsonian patients gain weight and to study its link with an energetic balance change.
Twenty parkinsonian patients will be randomised : the delay between inclusion and neurostimulation wil be lengthened 3 months for one group, compared to the second one. The energy expenditure, at rest and after ingestion of a test meal, will be compared between the group of patients that had been neurostimulated and the group whose intervention has been postponed. Weight changes, energy intake, leptin level, neurophysiological parameters will be compared between both groups, and the nature and repartition of the weight gain will be assessed in the neurostimulated group. An eventual link between motor factors, pharmacological factors, and gain weight will be studied.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- Age between 35 and 70; male or female; parkinson disease, with levo dopa response (at least 30%); severe but stable incapacity; no dementia, no psychosis, no depression; normal brain scanner done during the last 2 years.
- diabetes thyroid disease pacemaker coagulation troubles previous drug abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Deep brain stimulation Deep Brain Stimulation of the Subthalamic Nucleus 2 Deep brain stimulation Later Deep Brain Stimulation of the Subthalamic Nucleus
- Primary Outcome Measures
Name Time Method Measurement of energy expenditure with indirect calorimetry in open chamber: at rest in the morning, without 24h-dopaminergic treatment, and after dopaminergic treatment intake; and post prandial thermogenesis after a test meal. After surgery and at 3 months
- Secondary Outcome Measures
Name Time Method increase of energy intake At visit 1 and at 3 months UDPRS scale before surgery and after 3 months Weight gain At visit 1 and at 3 months cognitive and psychological assessments before surgery and after 3 months leptin, glucose, insulin blood levels At visite 1 and at 3 months
Trial Locations
- Locations (1)
Service de neurologie Hôpital Haut-Lévêque
🇫🇷Pessac, France